Torimura T - Search Results

1

Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study.

Casadei-Gardini A, Rimini M, Kudo M, Shimose S, Tada T, Suda G, Goh MJ, Jefremow A, Scartozzi M, Cabibbo G, Campani C, Tamburini E, Tovoli F, Ueshima K, Aoki T, Iwamoto H, Torimura T, Kumada T, Hiraoka A, Atsukawa M, Itobayashi E, Toyoda H, Sakamoto N, Sho T, Kang W, Siebler J, Neurath MF, Burgio V, Cascinu S. Casadei-Gardini A, et al. Among authors: torimura t. Liver Cancer. 2022 Jul 11;11(6):527-539. doi: 10.1159/000525145. eCollection 2022 Dec. Liver Cancer. 2022. PMID: 36589723 Free PMC article.

2

Intra-arterial therapy with cisplatin suspension in lipiodol and 5-fluorouracil for hepatocellular carcinoma with portal vein tumour thrombosis.

Nagamatsu H, Hiraki M, Mizukami N, Yoshida H, Iwamoto H, Sumie S, Torimura T, Sata M. Nagamatsu H, et al. Among authors: torimura t. Aliment Pharmacol Ther. 2010 Aug;32(4):543-50. doi: 10.1111/j.1365-2036.2010.04379.x. Epub 2010 May 25. Aliment Pharmacol Ther. 2010. PMID: 20500734 Free article.

3

Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan.

Nakano M, Ando E, Kuromatsu R, Torimura T, Sumie S, Takata A, Fukushima N, Kurogi J, Niizeki T, Iwamoto H, Tanaka M, Sata M. Nakano M, et al. Among authors: torimura t. Hepatol Res. 2010 Oct;40(10):989-96. doi: 10.1111/j.1872-034X.2010.00706.x. Hepatol Res. 2010. PMID: 20887334

4

Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy.

Niizeki T, Sumie S, Torimura T, Kurogi J, Kuromatsu R, Iwamoto H, Aino H, Nakano M, Kawaguchi A, Kakuma T, Sata M. Niizeki T, et al. Among authors: torimura t. J Gastroenterol. 2012 Jun;47(6):686-95. doi: 10.1007/s00535-012-0555-6. Epub 2012 Mar 1. J Gastroenterol. 2012. PMID: 22382631 Clinical Trial.

5

Vandetanib, an inhibitor of VEGF receptor-2 and EGF receptor, suppresses tumor development and improves prognosis of liver cancer in mice.

Inoue K, Torimura T, Nakamura T, Iwamoto H, Masuda H, Abe M, Hashimoto O, Koga H, Ueno T, Yano H, Sata M. Inoue K, et al. Among authors: torimura t. Clin Cancer Res. 2012 Jul 15;18(14):3924-33. doi: 10.1158/1078-0432.CCR-11-2041. Epub 2012 May 18. Clin Cancer Res. 2012. PMID: 22611027

6

Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model.

Sakamoto M, Nakamura T, Torimura T, Iwamoto H, Masuda H, Koga H, Abe M, Hashimoto O, Ueno T, Sata M. Sakamoto M, et al. Among authors: torimura t. J Gastroenterol Hepatol. 2013 Jan;28(1):168-78. doi: 10.1111/j.1440-1746.2012.07238.x. J Gastroenterol Hepatol. 2013. PMID: 22849788

7

Efficacy, safety, and survival factors for sorafenib treatment in Japanese patients with advanced hepatocellular carcinoma.

Nakano M, Tanaka M, Kuromatsu R, Nagamatsu H, Sakata K, Matsugaki S, Kajiwara M, Fukuizumi K, Tajiri N, Matsukuma N, Sakai T, Ono N, Yano Y, Koga H, Kurogi J, Takata A, Sumie S, Satani M, Yamada S, Niizeki T, Aino H, Iwamoto H, Torimura T, Sata M. Nakano M, et al. Among authors: torimura t. Oncology. 2013;84(2):108-14. doi: 10.1159/000342650. Epub 2012 Nov 9. Oncology. 2013. PMID: 23147476

8

Methylated-(3'')-epigallocatechin gallate analog suppresses tumor growth in Huh7 hepatoma cells via inhibition of angiogenesis.

Hashimoto O, Nakamura A, Nakamura T, Iwamoto H, Hiroshi M, Inoue K, Torimura T, Ueno T, Sata M. Hashimoto O, et al. Among authors: torimura t. Nutr Cancer. 2014;66(4):728-35. doi: 10.1080/01635581.2013.783601. Epub 2013 Sep 13. Nutr Cancer. 2014. PMID: 24033329

9

Metronomic chemotherapy: possible clinical application in advanced hepatocellular carcinoma.

Torimura T, Iwamoto H, Nakamura T, Koga H, Ueno T, Kerbel RS, Sata M. Torimura T, et al. Transl Oncol. 2013 Oct 1;6(5):511-9. doi: 10.1593/tlo.13481. eCollection 2013. Transl Oncol. 2013. PMID: 24151531 Free PMC article. Review.

10

Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis.

Aino H, Sumie S, Niizeki T, Kuromatsu R, Tajiri N, Nakano M, Satani M, Yamada S, Okamura S, Shimose S, Sumie H, Torimura T, Sata M. Aino H, et al. Among authors: torimura t. Mol Clin Oncol. 2014 May;2(3):393-398. doi: 10.3892/mco.2014.259. Epub 2014 Feb 14. Mol Clin Oncol. 2014. PMID: 24772306 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

322 results

Search Page